Resultado de búsqueda
Our R&D sets us apart – We offer the only RPM program with remote wheeze detection. By combining our innovative medical device technology with disruptive RPM program design, ask us how to create programs for underserved patient populations. Request a demo.
- Respiri UK
Connect the device to the respiri™ app via Bluetooth®. Place...
- Respiri US
Respiri can help transform the way patients experience care...
- About
Marjan has been at the helm of Respiri taking it from R&D to...
- Respiri UK
Respiri Limited (ASX:RSH, OTCQB:RSHUF) is an Australian e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US healthcare market. Respiri is listed on the Australian Securities Exchange (ASX) and trades on the OTCQB under the ticker “RSHUF” for North American based investors
29 de abr. de 2024 · About this app. wheezo® WheezeRate detector is a smartphone-based system consisting of a wheezo® breath sensor^, (device) and the respiri™ app. The device^ works with the respiri™ mobile app to...
Respiri leads the way in new technologies to better manage asthma, a chronic disease affecting over 330 million people worldwide and growing. Our unique prop...
Connect the device to the respiri™ app via Bluetooth®. Place device on windpipe to record breath sounds. Relax and breathe evenly for 30-60 seconds. The respiri™ mobile app runs a wheeze detection algorithm to identify wheeze and display a wheeze rate.
Respiri is a healthtech company providing devices and mobile apps for the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease.
8 de nov. de 2022 · Australian digital health company Respiri has started to roll out its digital remote patient monitoring (RPM) system for asthma and chronic obstructive pulmonary disease (COPD) in the US, with...
